Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-throughput multi-antigen microfluidic fluorescence immunoassays.

Emil P Kartalov1, Jiang F Zhong, Axel Scherer

  • 1Dept of Biochemistry and Molecular Biology, Keck School of Medicine, University of Southern California, Los Angeles 90033, USA. kartalov@usc.edu

Biotechniques
|February 4, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial Muscles: Electrostatic Actuation and Design Tradeoffs.

Biomimetics (Basel, Switzerland)·2026
Same author

p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.

Cancer research communications·2026
Same author

Plasmonic Moiré Superlattices for Robust Nanogap Cluster Formation.

Small methods·2026
Same author

FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

DeepDeconUQ estimates malignant cell fraction prediction intervals in bulk RNA-seq tissue.

PLoS computational biology·2025
Same author

Enhance the therapeutic efficacy of human umbilical cord-derived mesenchymal stem cells in prevention of acute graft-versus-host disease through CRISPLD2 modulation.

Stem cell research & therapy·2025
Same journal

Investigating the interactomic landscape of survival motor neuron (SMN) and the SMNΔ7 truncated protein.

BioTechniques·2026
Same journal

Antigen retrieval-immunofluorescence on free floating sections to visualize the liver lobule and its cellular makeup.

BioTechniques·2026
Same journal

Special approach of droplet digital polymerase chain reaction (ddPCR) for transgene stability of a Chinese hamster ovary (CHO) cell line.

BioTechniques·2026
Same journal

Strand-specific quantification of L1 ORF0 and related transcripts by multiplex reverse transcription with tagged primers.

BioTechniques·2026
Same journal

Why and when should we choose digital PCR?

BioTechniques·2026
Same journal

Quantitative and unbiased lung alveolar septum assessment in an LPS experimental mouse model using 2D-spatial correlation image analysis from hematoxylin and eosin slides.

BioTechniques·2026
See all related articles

A novel microfluidic immunoassay system enables high-throughput, multi-antigen testing using small sample volumes. This technology demonstrates high sensitivity for detecting biomarkers like C-reactive protein (CRP) and prostate-specific antigen (PSA).

Area of Science:

  • Biomedical Engineering
  • Analytical Chemistry
  • Biotechnology

Background:

  • Microfluidic devices offer miniaturized platforms for biological assays.
  • High-throughput screening is crucial for diagnostics and drug discovery.
  • Multiplexed immunoassays allow simultaneous detection of multiple analytes.

Purpose of the Study:

  • To develop a high-throughput microfluidic fluorescence immunoassay system.
  • To demonstrate the system's capability for multi-antigen detection.
  • To validate the system for sensitive and specific biomarker quantification.

Main Methods:

  • Fabrication of a 100-chamber polydimethylsiloxane (PDMS) microfluidic chip.
  • Development of a fluorescence immunoassay protocol for multiplexed detection.

Related Experiment Videos

  • Calibration and validation using specific biomarkers: C-reactive protein (CRP), prostate-specific antigen (PSA), ferritin, and vascular endothelial growth factor (VEGF).

    • Main Results:

    • The system successfully performed up to 5 tests for 10 samples concurrently.
    • Specific detection of target antigens was demonstrated.
    • Calibration curves showed high sensitivity, with a signal-to-noise ratio >8 at 10 pM for some analytes.
    • Assay requires only 100 nL of sample per test.

    Conclusions:

    • The developed microfluidic immunoassay system is a significant advancement for high-throughput, multiplexed biomarker detection.
    • The system exhibits high sensitivity and specificity, suitable for clinical research and point-of-care applications.
    • This technology paves the way for broader applications in diagnostics and personalized medicine.